MS has traditionally been thought of as a condition that mainly affects the white matter of the brain. Recently this notion has been challenged and now research has uncovered a potentially important disease process in the grey matter.
A new international study has mapped a type of immune cell, the microglia, in the human and mouse brain for the first time. Microglia are thought to play a role in the progression of MS. This research has changed the understanding of how these cells function, and has important implications for MS.
A new study has found that blocking the brain lymphatic vessels reduced MS-like illness in a laboratory model
A new study that suggests inflammation may lead to the death of brain cells in MS may have identified a drug that could block this process.
A study from MSIF McDonald fellow Dr Eshaghi has shown that brain tissue loss, or atrophy, occurs in ’stages’ and follows a predictable order.
New research suggests the rate of brain atrophy, or brain shrinkage, may be an important indicator of disease progression in MS.
Study reveals important mechanism that allows immune cells to attack myelin in MS
What’s behind the media reports on concussion and MS?